IBRX

IBRX Operating CF Margin

-169.57%TTM

Retrieved:

IBRX FY Operating CF Margin%
IBRX FY Operating CF Margin42324.33%-396177.52%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

IBRX operating cf margin history

Operating cash flow as percentage of revenue. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Immunitybio Inc Operating CF Margin — Annual fiscal periods
Period endingOperating CF Margin
-269.1688%
-2,653.3469%
-58,964.1479%
-140,628.75%
-29,381.0493%
-28,384.1322%
-353,741.8605%
-134,853.1915%
-108,400%
-87,711.3636%
-10,722.4576%
-835.2574%
-111.3333%

Compare operating cf margin

All IBRX financial metrics · IBRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.